Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer

Valentin al Jalali, Gabriel Wasinger, Sazan Rasul, Bernhard Grubmüller, Beatrix Wulkersdorfer, Theresa Balber, Markus Mitterhauser, Judit Simon, Marcus Hacker, Shahrokh Shariat, Gerda Egger and Markus Zeitlinger
Journal of Nuclear Medicine June 2023, 64 (6) 863-868; DOI: https://doi.org/10.2967/jnumed.122.264981
Valentin al Jalali
1Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria;
2Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Wasinger
3Department of Pathology, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sazan Rasul
4Division of Nuclear Medicine, Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Grubmüller
5Department of Urology and Andrology, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatrix Wulkersdorfer
1Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria;
2Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theresa Balber
1Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria;
4Division of Nuclear Medicine, Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Mitterhauser
1Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria;
4Division of Nuclear Medicine, Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria;
6Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judit Simon
1Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria;
7Department of Health Economics, Center for Public Health, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Hacker
4Division of Nuclear Medicine, Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shahrokh Shariat
8Department of Urology, Medical University of Vienna, Vienna, Austria; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerda Egger
1Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria;
3Department of Pathology, Medical University of Vienna, Vienna, Austria;
9Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Zeitlinger
1Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria;
2Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 6 863-868
DOI 
https://doi.org/10.2967/jnumed.122.264981
PubMed 
36657982

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 10, 2022
  • Revision received January 12, 2023
  • Published online June 1, 2023.

Article Versions

  • previous version (January 19, 2023 - 12:04).
  • previous version (February 2, 2023 - 12:06).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Valentin al Jalali1,2,
  2. Gabriel Wasinger3,
  3. Sazan Rasul4,
  4. Bernhard Grubmüller5,
  5. Beatrix Wulkersdorfer1,2,
  6. Theresa Balber1,4,
  7. Markus Mitterhauser1,4,6,
  8. Judit Simon1,7,
  9. Marcus Hacker4,
  10. Shahrokh Shariat8,
  11. Gerda Egger1,3,9 and
  12. Markus Zeitlinger1,2
  1. 1Ludwig Boltzmann Institute Applied Diagnostics, Vienna, Austria;
  2. 2Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria;
  3. 3Department of Pathology, Medical University of Vienna, Vienna, Austria;
  4. 4Division of Nuclear Medicine, Department of Biomedical Imaging and Image Guided Therapy, Medical University of Vienna, Vienna, Austria;
  5. 5Department of Urology and Andrology, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems, Austria;
  6. 6Institute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria;
  7. 7Department of Health Economics, Center for Public Health, Medical University of Vienna, Vienna, Austria;
  8. 8Department of Urology, Medical University of Vienna, Vienna, Austria; and
  9. 9Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
  1. For correspondence or reprints, contact Markus Zeitlinger (markus.zeitlinger{at}meduniwien.ac.at).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 7 Citations
  • 7 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Androgen Receptor Imaging in the Management of Hormone-Dependent Cancers with Emphasis on Prostate Cancer
    Kalevi Kairemo, Marina Hodolic
    International Journal of Molecular Sciences 2023 24 9
  • [18F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review
    Luca Filippi, Luca Urso, Orazio Schillaci, Laura Evangelista
    Diagnostics 2023 13 15
  • Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers
    Martina Sollini, Jeremie Calais, Arturo Chiti, Louise Emmett, Stefano Fanti, Wolfgang Fendler, Ken Herrmann, Thomas A. Hope, Oliver Sartor, Brian Shuch, Scott Tagawa, Michael S. Hofman
    European Urology 2025 87 2
  • Les radiotraceurs autres que le PSMA-ligand pour l’imagerie TEP du cancer de prostate
    N. Withofs, R. Hustinx, C. Morgat
    Médecine Nucléaire 2023 47 5
  • Prospective comparison of 18F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer
    Aino Kivikallio, Simona Malaspina, Irena Saarinen, Marko Seppänen, Mikael Anttinen, Ivan Jambor, Janne Verho, Jukka Kemppainen, Hannu J. Aronen, Peter J. Boström, Otto Ettala, Pekka Taimen
    European Journal of Nuclear Medicine and Molecular Imaging 2025
  • Prostate Cancer from a Nuclear Oncology Perspective
    Kalevi Kairemo
    2025
  • [18F]FDHT tumour imaging for predicting response to treatment based on androgen receptor
    Abdullah Mujahid Muhammad, Wenhao Dun, Zarif Ashhar, Muhammad Fakhrurazi Ahmad Fadzil
    Journal of Radioanalytical and Nuclear Chemistry 2024 333 10

Article usage

Article usage: January 2023 to April 2025

AbstractFullPdf
Jan 20231917052
Feb 20231578026
Mar 2023525014
Apr 202329707
May 2023263013
Jun 202312254736
Jul 20235042024
Aug 20234531112
Sep 20233701524
Oct 20231683619
Nov 20238912640
Dec 2023398533
Jan 20245316535
Feb 20243323230
Mar 20242414325
Apr 2024617125
May 2024397235
Jun 2024747531
Jul 202420213650
Aug 202420810547
Sep 2024583942
Oct 2024263738
Nov 2024263126
Dec 2024284323
Jan 2025323620
Feb 2025336431
Mar 2025194636
Apr 2025224648
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (6)
Journal of Nuclear Medicine
Vol. 64, Issue 6
June 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer
Valentin al Jalali, Gabriel Wasinger, Sazan Rasul, Bernhard Grubmüller, Beatrix Wulkersdorfer, Theresa Balber, Markus Mitterhauser, Judit Simon, Marcus Hacker, Shahrokh Shariat, Gerda Egger, Markus Zeitlinger
Journal of Nuclear Medicine Jun 2023, 64 (6) 863-868; DOI: 10.2967/jnumed.122.264981

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Consecutive Prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve Prostate Cancer
Valentin al Jalali, Gabriel Wasinger, Sazan Rasul, Bernhard Grubmüller, Beatrix Wulkersdorfer, Theresa Balber, Markus Mitterhauser, Judit Simon, Marcus Hacker, Shahrokh Shariat, Gerda Egger, Markus Zeitlinger
Journal of Nuclear Medicine Jun 2023, 64 (6) 863-868; DOI: 10.2967/jnumed.122.264981
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • [18F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease
  • Whole-Body [18F]DPA-714 Kinetic Assessment Using PET/CT Scanner with Long Axial Field of View
  • Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience
Show more Clinical Investigation

Similar Articles

Keywords

  • [68Ga]PSMA PET
  • [18F]FDHT PET
  • AR protein expression
  • PSMA protein expression
  • primary hormone-naïve prostate cancer
SNMMI

© 2025 SNMMI

Powered by HighWire